206 related articles for article (PubMed ID: 22519449)
21. Matrix metalloproteinases: their biological functions and clinical implications.
Hijova E
Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases and vulnerable atheromatous plaque.
Toutouzas K; Synetos A; Nikolaou C; Tsiamis E; Tousoulis D; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1166-80. PubMed ID: 22519447
[TBL] [Abstract][Full Text] [Related]
23. Proteinases and plaque rupture: unblocking the road to translation.
Newby AC
Curr Opin Lipidol; 2014 Oct; 25(5):358-66. PubMed ID: 25089553
[TBL] [Abstract][Full Text] [Related]
24. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases in vascular physiology and disease.
Siefert SA; Sarkar R
Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
[TBL] [Abstract][Full Text] [Related]
26. Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation.
Newby AC
Matrix Biol; 2015; 44-46():157-66. PubMed ID: 25636537
[TBL] [Abstract][Full Text] [Related]
27. Contributory role of matrix metalloproteinases in cardiovascular remodeling.
Gunasinghe SK; Ikonomidis J; Spinale FG
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Dec; 1(2):75-91. PubMed ID: 12769658
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability.
Xie S; Nie R; Wang J
J Postgrad Med; 2009; 55(4):284-6. PubMed ID: 20083879
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases in atherothrombosis.
Bäck M; Ketelhuth DF; Agewall S
Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959
[TBL] [Abstract][Full Text] [Related]
30. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
Li YY; McTiernan CF; Feldman AM
Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
32. Vascular extracellular matrix in atherosclerosis.
Chistiakov DA; Sobenin IA; Orekhov AN
Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
[TBL] [Abstract][Full Text] [Related]
33. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
Newby AC
Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerotic plaque stability--what determines the fate of a plaque?
Halvorsen B; Otterdal K; Dahl TB; Skjelland M; Gullestad L; Øie E; Aukrust P
Prog Cardiovasc Dis; 2008; 51(3):183-94. PubMed ID: 19026853
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases and atherogenesis in dependence of age.
Kunz J
Gerontology; 2007; 53(2):63-73. PubMed ID: 17047333
[TBL] [Abstract][Full Text] [Related]
37. Specific matrix metalloproteinases play different roles in intraplaque angiogenesis and plaque instability in rabbits.
Liu XQ; Mao Y; Wang B; Lu XT; Bai WW; Sun YY; Liu Y; Liu HM; Zhang L; Zhao YX; Zhang Y
PLoS One; 2014; 9(9):e107851. PubMed ID: 25233229
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases: a potential therapeutic target in atherosclerosis.
Rouis M
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):541-8. PubMed ID: 16503874
[TBL] [Abstract][Full Text] [Related]
39. Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels.
Ezhov M; Safarova M; Afanasieva O; Mitroshkin M; Matchin Y; Pokrovsky S
Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30934954
[TBL] [Abstract][Full Text] [Related]
40. The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome.
Gostiljac D; Dorđević PB; Djurić D; Peruničić J; Lasica R; Colak E; Canovic F; Srećković VD; Ilić M; Obrenović R
Acta Physiol Hung; 2011 Mar; 98(1):91-7. PubMed ID: 21388935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
